KRAS and pancreatic neoplasm: Thus, we introduced a conditional knock-in for KRAS-K128R mutation in the pancreatic cancer cell line SW1990 harboring a homozygous KRAS-G12D mutation (Fig. 5A; Appendix Figs. S7 and  S9A).